These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 3201523)
1. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523 [TBL] [Abstract][Full Text] [Related]
2. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation. Konsil J; Dechasathian S; Mason DH; Stevens RE J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869 [TBL] [Abstract][Full Text] [Related]
3. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide. Tomson T; Tybring G; Bertilsson L Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300 [TBL] [Abstract][Full Text] [Related]
4. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism. Tomson T; Svensson JO; Hilton-Brown P Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227 [TBL] [Abstract][Full Text] [Related]
5. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects. Eichelbaum M; Tomson T; Tybring G; Bertilsson L Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637 [TBL] [Abstract][Full Text] [Related]
6. Diclofenac and metabolite pharmacokinetics in children. van der Marel CD; Anderson BJ; Rømsing J; Jacqz-Aigrain E; Tibboel D Paediatr Anaesth; 2004 Jun; 14(6):443-51. PubMed ID: 15153204 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults. Chien S; Bialer M; Solanki B; Verhaeghe T; Doose DR; Novak G; Yao C Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models. Fortuna A; Alves G; Soares-da-Silva P; Falcão A Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973 [TBL] [Abstract][Full Text] [Related]
9. Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose. Harder JL; Heung M; Vilay AM; Mueller BA; Segal JH Hemodial Int; 2011 Jul; 15(3):412-5. PubMed ID: 21676154 [TBL] [Abstract][Full Text] [Related]
10. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy. Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690 [TBL] [Abstract][Full Text] [Related]
11. Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules. Garnett WR; McLean AM; Zhang Y; Clausen S; Tulloch SJ Curr Med Res Opin; 2003; 19(6):519-25. PubMed ID: 14594524 [TBL] [Abstract][Full Text] [Related]
12. Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s). Madden S; Maggs JL; Park BK Drug Metab Dispos; 1996 Apr; 24(4):469-79. PubMed ID: 8801063 [TBL] [Abstract][Full Text] [Related]
13. Effect of flurithromycin, a new macrolide antibiotic, on carbamazepine disposition in normal subjects. Barzaghi N; Gatti G; Crema F; Faja A; Monteleone M; Amione C; Leone L; Perucca E Int J Clin Pharmacol Res; 1988; 8(2):101-5. PubMed ID: 3378851 [TBL] [Abstract][Full Text] [Related]
14. Individual and combined antiepileptic and neurotoxic activity of carbamazepine and carbamazepine-10,11-epoxide in mice. Bourgeois BF; Wad N J Pharmacol Exp Ther; 1984 Nov; 231(2):411-5. PubMed ID: 6491988 [TBL] [Abstract][Full Text] [Related]
15. Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure control. Theodore WH; Narang PK; Holmes MD; Reeves P; Nice FJ Ann Neurol; 1989 Feb; 25(2):194-6. PubMed ID: 2919868 [TBL] [Abstract][Full Text] [Related]
16. Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. Spina E; Martines C; Fazio A; Trio R; Pisani F; Tomson T Ther Drug Monit; 1991 Mar; 13(2):109-12. PubMed ID: 2053116 [TBL] [Abstract][Full Text] [Related]
17. Early stage autoinduction of carbamazepine metabolism in humans. Bernus I; Dickinson RG; Hooper WD; Eadie MJ Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine. Britzi M; Perucca E; Soback S; Levy RH; Fattore C; Crema F; Gatti G; Doose DR; Maryanoff BE; Bialer M Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535 [TBL] [Abstract][Full Text] [Related]
19. Carbamazepine-danazol drug interaction: its mechanism examined by a stable isotope technique. Krämer G; Theisohn M; von Unruh GE; Eichelbaum M Ther Drug Monit; 1986; 8(4):387-92. PubMed ID: 3824425 [TBL] [Abstract][Full Text] [Related]
20. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase? Svinarov DA; Pippenger CE Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]